Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours Β· Estimated delivery Sep 28 - Oct 3
The correct framing is that the design is explored to test whether multi pathway signalling produces measurable changes across a broader endpoint panel than single component designs
These encouraging results mean that prospective trials are needed to determine whether GLP-1 receptor agonists can be repurposed as gerotherapeutics, say the authors
Journal of Physiology and Biochemistry, 69 (3), 451458
Risk of glaucoma in patients without diabetes using a glucagon-like peptide 1 receptor agonist
US$ 25.43
US$ 27.52
US$ 23.55
US$ 21.65
